Three Lakes Partners

Three Lakes Partners operates as a venture philanthropy, accelerating innovative diagnostics and devices for Idiopathic Pulmonary Fibrosis (IPF). The organization strategically funds solutions through challenges and collaborations. Their technical approach focuses on improving early diagnosis and developing effective treatments, propelling scientific advancement within this disease area.

Founded in 2017, Three Lakes Partners emerged from the critical insight that Idiopathic Pulmonary Fibrosis, despite its severity, receives insufficient research and funding. This neglect causes a significant gap in innovative solutions and patient resources. Led by Executive Director Dana Ball and CEO Bill Athenson, the venture philanthropy was formed to address this underserved medical need.

Patients affected by Idiopathic Pulmonary Fibrosis and their caregivers are the primary beneficiaries of Three Lakes Partners' efforts. The company's mission is to eradicate IPF entirely by cultivating a global network of dedicated partners. Its forward-looking vision centers on discovering a definitive cure for this debilitating condition, transforming patient outcomes.